Parvin alpha antibody (N-Term)
Quick Overview for Parvin alpha antibody (N-Term) (ABIN325027)
Target
See all Parvin alpha (PARVA) AntibodiesReactivity
Host
Clonality
Conjugate
Application
- 
    - 
                                            Binding Specificity
- N-Term
- 
                                            Specificity
- Detects endogenous levels of total -parvin protein.
- 
                                            Purification
- Immunoaffinity purified
- 
                                            Immunogen
- 
                        Synthetic peptide (KLH-coupled) corresponding to residues near the amino terminus of human -parvin.
 Type of Immunogen: Synthetic peptide
- 
                                            Isotype
- IgG
 
- 
                                            
- 
    
- 
    - 
                                            Application Notes
- 
                        Approved: WB (1:1000)
 Usage: Suitable for use in Western Blot. Western Blot: 1:1000.
- 
                                            Comment
- 
                        Target Species of Antibody: Human 
- 
                                            Restrictions
- For Research Use only
 
- 
                                            
- 
    - 
                                            Format
- Liquid
- 
                                            Concentration
- Lot specific
- 
                                            Buffer
- 10 mM sodium HEPES, pH 7.5, 150 mM sodium chloride, 100 g/mL BSA, 50 % glycerol.
 
- 
                                            
- 
    - Parvin alpha (PARVA) (Parvin, alpha (PARVA))
- 
                                            Alternative Name
- PARVA
- 
                                            Background
- 
                        Name/Gene ID: PARVA
 Synonyms: PARVA, Actopaxin, Alpha-parvin, CH-ILKBP, Parvin, alpha, MXRA2
- 
                                            Gene ID
- 55742
- 
                                            UniProt
- Q9NVD7
- 
                                            Pathways
- Smooth Muscle Cell Migration
 Target
- 
                    
 
                                     
                                     
                                    